The frontiers of the life sciences industry are constantly expanding, with every day bringing new discoveries, regulations, and challenges for companies and industry professionals. Goldberg Segalla’s Life Science Matters blog is your guide to navigating the increasingly complex and rapidly evolving fields of biotechnology, cannabis, over-the-counter drugs, pharmaceuticals, nutraceuticals, medical devices, and other health-related products and services. Our contributing attorneys have decades of experience representing U.S. and international companies of all sizes in this highly regulated industry in all stages of business, from new product development and testing all the way through manufacturing, marketing, distribution, and advertising. From case result analysis to news about medical, scientific, and business innovations, the Life Science Matters blog will break down what you need to know — and why.
Sean Stadelman is a partner in the firm’s Philadelphia office. He has experience litigating complex product liability, commercial, and professional liability matters in both federal and state courts involving single plaintiffs and large, consolidated mass actions. He works with clients in a variety of industries, including medical device manufacturers, vehicle manufacturers and trucking companies, and consumer product businesses.
Michael Shalhoub is a trial lawyer who has extensive experience advising companies, large and small, about the life sciences world. He has been selected for inclusion in the New York Best Lawyers and New York Super Lawyers for a number of years, and was named to the Super Lawyers Top 25 Attorneys in Westchester County Super Lawyers list for several years. He is a past member of the Board of Directors of the DRI – The Voice of the Defense Bar; a past Chair of DRI’s Medical Liability and Health Care Law Committee; and a past Chair of the Federation of Defense and Corporate Counsel’s Drug, Medical Device and Biotechnology Section, and its current Products Liability Section Chair.
Joseph Welter is a partner of Goldberg Segalla, where his practice has included the representation of companies and carriers in product liability, pharmaceutical, medical device, and toxic tort litigation. He has litigated and managed mass tort claims across the country in the pharmaceutical and medical device areas, which has included federal court multi-district litigations and state court mass tort programs. Joe has worked with clients to develop effective strategic litigation plans and settlement matrixes for mass tort claims in this unique litigation setting. Over the past 20 years, he has also served as national and local trial counsel for prominent manufacturers, distributors and contractors in asbestos litigation in New York and Pennsylvania.
H. Lockwood (Chip) Miller III
H. Lockwood (Chip) Miller III has broad litigation experience across a number of substantive areas, with a deep focus on the defense of product liability and toxic tort claims in single-plaintiff cases and large, consolidated mass actions. Chip has defended a wide array of product liability and toxic tort claims, including matters involving asbestos, cosmetics and personal care products, lead paint, chemicals and chemical compounds, benzene, household and consumer products, butane-fueled lighters, material handling equipment, airline service equipment, alarm and signaling systems, industrial products, and playground equipment. He is an active member of the Defense Research Institute (DRI) Product Liability Committee. He currently serves as its Marketing Liaison for the Chemical and Toxic Torts Specialized Litigation Group. He also currently serves as a member of the New Jersey Defense Association Products Liability Committee and the New Jersey Supreme Court District XB Ethics Committee.